Corteva, Inc. (NYSE:CTVA - Free Report) - KeyCorp issued their Q1 2025 earnings estimates for Corteva in a report released on Sunday, April 13th. KeyCorp analyst A. Yefremov expects that the company will earn $0.87 per share for the quarter. KeyCorp currently has a "Overweight" rating and a $71.00 target price on the stock. The consensus estimate for Corteva's current full-year earnings is $2.96 per share. KeyCorp also issued estimates for Corteva's Q2 2025 earnings at $2.07 EPS, Q3 2025 earnings at ($0.27) EPS, Q4 2025 earnings at $0.37 EPS and FY2025 earnings at $3.03 EPS.
A number of other research analysts have also weighed in on CTVA. Citigroup raised their price objective on Corteva from $69.00 to $74.00 and gave the company a "buy" rating in a research report on Wednesday, January 29th. Argus raised shares of Corteva from a "hold" rating to a "buy" rating and set a $69.00 price target for the company in a research report on Monday, March 31st. Royal Bank of Canada upped their price objective on Corteva from $72.00 to $73.00 and gave the company an "outperform" rating in a research report on Friday, February 7th. UBS Group lowered their target price on Corteva from $74.00 to $73.00 and set a "buy" rating on the stock in a report on Friday, January 10th. Finally, Bank of America increased their target price on shares of Corteva from $69.00 to $73.00 and gave the stock a "buy" rating in a report on Tuesday, February 11th. One analyst has rated the stock with a sell rating, three have issued a hold rating and fourteen have issued a buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $68.13.
Read Our Latest Analysis on CTVA
Corteva Stock Up 0.8 %
Shares of NYSE CTVA traded up $0.49 during mid-day trading on Wednesday, hitting $59.69. 3,661,138 shares of the stock traded hands, compared to its average volume of 3,314,795. The company has a debt-to-equity ratio of 0.08, a quick ratio of 0.93 and a current ratio of 1.45. The stock has a fifty day moving average price of $60.97 and a 200-day moving average price of $60.28. The company has a market cap of $40.77 billion, a price-to-earnings ratio of 46.27, a PEG ratio of 1.68 and a beta of 0.73. Corteva has a 52 week low of $50.01 and a 52 week high of $66.24.
Corteva (NYSE:CTVA - Get Free Report) last announced its quarterly earnings results on Wednesday, February 5th. The company reported $0.32 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.34 by ($0.02). Corteva had a net margin of 5.36% and a return on equity of 7.19%.
Corteva Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Monday, March 17th. Investors of record on Monday, March 3rd were issued a $0.17 dividend. The ex-dividend date was Monday, March 3rd. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.14%. Corteva's payout ratio is 52.71%.
Insiders Place Their Bets
In other news, insider Brian Titus sold 26,560 shares of the company's stock in a transaction that occurred on Thursday, February 20th. The shares were sold at an average price of $63.74, for a total value of $1,692,934.40. Following the completion of the sale, the insider now owns 11,347 shares of the company's stock, valued at approximately $723,257.78. This represents a 70.07 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 0.14% of the stock is currently owned by company insiders.
Hedge Funds Weigh In On Corteva
A number of large investors have recently bought and sold shares of CTVA. Flagship Wealth Advisors LLC bought a new stake in Corteva during the fourth quarter valued at about $25,000. Noble Wealth Management PBC purchased a new stake in shares of Corteva in the fourth quarter worth about $26,000. Hager Investment Management Services LLC purchased a new stake in Corteva in the 4th quarter worth approximately $27,000. Pinney & Scofield Inc. acquired a new stake in shares of Corteva during the 4th quarter worth approximately $27,000. Finally, LGT Financial Advisors LLC purchased a new position in shares of Corteva during the 4th quarter valued at approximately $31,000. Institutional investors own 81.54% of the company's stock.
Corteva Company Profile
(
Get Free Report)
Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.
Featured Stories
Before you consider Corteva, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Corteva wasn't on the list.
While Corteva currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.